Sands Capital Alternatives as of June 30, 2025
Portfolio Holdings for Sands Capital Alternatives
Sands Capital Alternatives holds 19 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Klaviyo Com Ser A (KVYO) | 23.2 | $118M | 3.5M | 33.58 | |
| Nu Hldgs Ord Shs Cl A (NU) | 19.4 | $98M | 7.2M | 13.72 | |
| Doordash Cl A (DASH) | 18.5 | $94M | 381k | 246.51 | |
| Beta Bionics (BBNX) | 10.2 | $52M | 3.6M | 14.56 | |
| Coupang Cl A (CPNG) | 5.0 | $25M | 849k | 29.96 | |
| Inhibikase Therapeutics Com New (IKT) | 4.2 | $21M | 11M | 1.95 | |
| Monday SHS (MNDY) | 3.6 | $18M | 58k | 314.48 | |
| Samsara Com Cl A (IOT) | 3.4 | $17M | 439k | 39.78 | |
| Datadog Cl A Com (DDOG) | 3.1 | $16M | 119k | 134.33 | |
| Crowdstrike Hldgs Cl A (CRWD) | 1.6 | $8.0M | 16k | 509.31 | |
| Toast Cl A (TOST) | 1.4 | $6.9M | 157k | 44.29 | |
| Tarsus Pharmaceuticals (TARS) | 1.4 | $6.9M | 170k | 40.51 | |
| Snowflake Cl A (SNOW) | 1.2 | $6.0M | 27k | 223.77 | |
| 10x Genomics Cl A Com (TXG) | 1.1 | $5.6M | 482k | 11.58 | |
| Acumen Pharmaceuticals (ABOS) | 0.8 | $4.0M | 3.4M | 1.16 | |
| Bioage Labs (BIOA) | 0.6 | $3.2M | 786k | 4.13 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.5 | $2.5M | 2.1M | 1.19 | |
| Candel Therapeutics (CADL) | 0.4 | $2.1M | 406k | 5.06 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $1.7M | 725k | 2.31 |
